Table 1.

Key demographic and clinical characteristics of the previously published cases of Strongyloidiasis in persons with COVID-19.

Reference	Patient Age (Years) and Sex	Reporting Country	Patient’s Country of Birth	Time Since Immigration (Years)	COVID-19 Treatment	Strongyloides Diagnostic Methods Used	Estimated Interval Between COVID-19 Symptom Onset and Strongyloides Diagnosis (Days)	Diagnosis	Strongyloides Treatment	Outcome
Kim [15]	63 M	United States (California)	Cambodia	NS	Dexamethasone, barcitinib	Stool exam negative; BAL fluid microscopy positive; serology positive	28	SHS	Ivermectin	Died
Gautam [16]	53 M	India	India	NA	Methylprednisolone	Stool exam positive	60	SHS	Ivermectin and albendazole	Survived
Lier [17]	68 M	United States (Connecticut)	Ecuador	20	Methylprednisolone, tocilizumab	Stool exam negative; sputum sample positive	27	SHS	Ivermectin and albendazole	Survived
Núñez-Gómez [18]	45 M	Spain	Ecuador	20	Dexamethasone	Stool exam positive; Serology positive	12	SHS	Ivermectin	Survived
O’Dowling [19]	60 F	Ireland	Nigeria	22	None	Serology positive; pathology of small bowel resected with parasites	NA (asymptomatic SARS-CoV-2)	SHS	Ivermectin	Survived
Babazadeh [20]	70 M	Iran	Iran	NA	Dexamethasone	Histopathology of gastric and duodenal biopsy	21	SHS	Ivermectin and albendazole	Survived
Patel [21]	72 M	United States	Nicaragua	NS	Dexamethasone	Stool exam positive; BAL fluid microscopy	NS	SHS	Ivermectin	Survived
Marchese [22]	59 F	Northern Italy	Southern Italy	NS	Dexamethasone, tocilizumab	Stool exam positive; serology positive	32	Chronic strongyloidiasis	Ivermectin	Survived
Feria [23]	44 M	Spain	Bolivia	17	Dexamethasone	Serology positive	7	Chronic strongyloidiasis	Ivermectin	Survived
Feria [23]	74 F	Spain	Honduras	7	Dexamethasone	Serology positive	10	Chronic strongyloidiasis	Ivermectin	Survived
Pintos-Pascual [24]	70 M	Spain	Ecuador	12	Methylprednisolone, tocilizumab, anakinra	Stool exam positive; serology positive	55	Chronic strongyloidiasis	Ivermectin and albendazole	Survived
Alkaabba [25]	76 M	United States	United States	NA	Dexamethasone	Stool exam positive; histopathology of duodenum	14	Chronic strongyloidiasis	Ivermectin	Survived
Busaidi [26]	55 M	Oman	Oman	NA	Dexamethasone	Stool exam positive	30	Chronic strongyloidiasis	Ivermectin and albendazole	Survived
Stylemans [27]	59 M	Belgium	Ecuador	7	Methylprednisolone, anakinra	PCR on stool exam positive; serology positive	60	Chronic strongyloidiasis	Ivermectin	Survived
Singh [28]	58 M	India	India	NA	Methylprednisolone	Stool exam positive	6	Chronic strongyloidiasis	Ivermectin and albendazole	Survived
Lorenzo [29]	37 F	Spain	Bolivia	NS	Steroids	Serology positive	NS	Chronic strongyloidiasis	NS	Survived
Lorenzo [29]	47 F	Spain	Bolivia	NS	Steroids	Serology positive	NS	Chronic strongyloidiasis	NS	Survived
Lorenzo [29]	33 F	Spain	Honduras	NS	Steroids	Serology positive	NS	Chronic strongyloidiasis	NS	Survived
Lorenzo [29]	38 M	Spain	Honduras	NS	No steroids or tocilizumab	Serology positive	NS	Chronic strongyloidiasis	NS	Survived
Lorenzo [29]	22 M	Spain	Morocco	NS	No steroids or tocilizumab ^	Serology positive	NS	Chronic strongyloidiasis	NS	Survived
Lorenzo [29]	69 F	Spain	Columbia	NS	No steroids or tocilizumab	Serology positive	NS	Chronic strongyloidiasis	NS	Survived
Lorenzo [29]	27 F	Spain	Peru	NS	No steroids or tocilizumab	Serology positive	NS	Chronic strongyloidiasis	NS	Survived

M = male, F = female, NS = not specified, NA = not applicable. ^ This patient did not receive corticosteroids for COVID-19 but was receiving infliximab, adalimumab, corticosteroids, and azathioprine for Crohn’s disease.